Identification of unique venous thromboembolism-susceptibility variants in African-Americans.

Heit JA1, Armasu SM, McCauley BM, Kullo IJ, Sicotte H, Pathak J, Chute CG, Gottesman O, Bottinger EP, Denny JC, Roden DM, Li R, Ritchie MD, de Andrade M.

Author information

Abstract

To identify novel single nucleotide polymorphisms (SNPs) associated with venous thromboembolism (VTE) in African-Americans (AAs), we performed a genome-wide association study (GWAS) of VTE in AAs using the Electronic Medical Records and Genomics (eMERGE) Network, comprised of seven sites each with DNA biobanks (total ~39,200 unique DNA samples) with genome-wide SNP data (imputed to 1000 Genomes Project cosmopolitan reference panel) and linked to electronic health records (EHRs). Using a validated EHR-driven phenotype extraction algorithm, we identified VTE cases and controls and tested for an association between each SNP and VTE using unconditional logistic regression, adjusted for age, sex, stroke, site-platform combination and sickle cell risk genotype. Among 393 AA VTE cases and 4,941 AA controls, three intragenic SNPs reached genome-wide significance: LEMD3 rs138916004 (OR=3.2; p=1.3E-08), LY86 rs3804476 (OR=1.8; p=2E-08) and LOC100130298 rs142143628 (OR=4.5; p=4.4E-08); all three SNPs validated using internal cross-validation, parametric bootstrap and meta-analysis methods. LEMD3 rs138916004 and LOC100130298 rs142143628 are only present in Africans (1000G data). LEMD3 showed a significant differential expression in both NCBI Gene Expression Omnibus (GEO) and the Mayo Clinic gene expression data, LOC100130298 showed a significant differential expression only in the GEO expression data, and LY86 showed a significant differential expression only in the Mayo expression data. LEMD3 encodes for an antagonist of TGF-β-induced cell proliferation arrest. LY86 encodes for MD-1down-regulates the pro-inflammatory response to lipopolysaccharide; LY86 variation was previously associated with VTE in white women; LOC100130298 is a non-coding RNA gene with unknown regulatory activity in gene expression and epigenetics.

KEYWORDS:

African Americans; Genetic variation; association analyses; venous thromboembolism

PMID:: 28203683
DOI:: 10.1160/TH16-08-0652

From HuGE Literature Finder Database

This database contains published literature on genetic associations and other human genome epidemiology

Identification of unique venous thromboembolism-susceptibility variants in African-Americans.
Thrombosis and haemostasis 2017 Feb .
Heit John A, Armasu Sebastian M, McCauley Bryan M, Kullo Iftikhar J, Sicotte Hugues, Pathak Jyotishman, Chute Christopher G, Gottesman Omri, Bottinger Erwin P, Denny Joshua C, Roden Dan M, Li Rongling, Ritchie Marylyn D, de Andrade Mari
Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2017 Jan 1076029616686716.
Ahmad Abrar, Sundquist Kristina, Zöller Bengt, Svensson Peter J, Sundquist Jan, Memon Ashfaque
Rare genetic variants in SMAP1, B3GAT2 and RIMS1 contribute to pediatric venous thromboembolism.
Blood 2016 Dec .
Rühle Frank, Witten Anika, Barysenka Andrei, Huge Andreas, Arning Astrid, Heller Christine, Krümpel Anne, Mesters Rolf, Franke Andre, Lieb Wolfgang, Riemenschneider Mona, Hiersche Milan, Limperger Verena, Nowak-Göttl Ulrike, Stoll Moni
Development of a risk prediction score for occult cancer in patients with venous thromboembolism.
Chest 2016 Nov .
Jara-Palomares Luis, Otero Remedios, Jimenez David, Carrier Marc, Tzoran Inna, Brenner Benjamin, Margeli Mireia, Praena-Fernandez Juan Manuel, Grandone Elvira, Monreal Manuel,
Genotypes and phenotypes of protein S deficiency in Thai children with thromboembolism.
Pediatric blood & cancer 2016 Oct .
Komwilaisak Patcharee, Sasanakul Werasak, Chuansumrit Ampaiwan, Kanjanapongkul Somjai, Wangruangsathit Somporn, Lusawat Apasri, Charoenkwan Pimlak, Sirachainan Nongnu